These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 20224722)
1. YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas. Horbinski C; Wang G; Wiley CA Int J Clin Exp Pathol; 2010 Jan; 3(3):226-37. PubMed ID: 20224722 [TBL] [Abstract][Full Text] [Related]
2. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. Pelloski CE; Mahajan A; Maor M; Chang EL; Woo S; Gilbert M; Colman H; Yang H; Ledoux A; Blair H; Passe S; Jenkins RB; Aldape KD Clin Cancer Res; 2005 May; 11(9):3326-34. PubMed ID: 15867231 [TBL] [Abstract][Full Text] [Related]
3. Association between YKL-40 and adult primary astrocytoma. Zhang W; Kawanishi M; Miyake K; Kagawa M; Kawai N; Murao K; Nishiyama A; Fei Z; Zhang X; Tamiya T Cancer; 2010 Jun; 116(11):2688-97. PubMed ID: 20499402 [TBL] [Abstract][Full Text] [Related]
4. Protein and mRNA levels of YKL-40 in high-grade glioma. Kazakova MH; Staneva DN; Koev IG; Staikov DG; Mateva N; Timonov PT; Miloshev GA; Sarafian VS Folia Biol (Praha); 2014; 60(6):261-7. PubMed ID: 25629266 [TBL] [Abstract][Full Text] [Related]
5. YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas. Nutt CL; Betensky RA; Brower MA; Batchelor TT; Louis DN; Stemmer-Rachamimov AO Clin Cancer Res; 2005 Mar; 11(6):2258-64. PubMed ID: 15788675 [TBL] [Abstract][Full Text] [Related]
6. Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms. Singh VY; Chacko G; Chacko AG; Rajshekhar V Neurol India; 2014; 62(1):32-6. PubMed ID: 24608451 [TBL] [Abstract][Full Text] [Related]
7. High CHI3L1 expression is associated with glioma patient survival. Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858 [TBL] [Abstract][Full Text] [Related]
8. YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas. Hormigo A; Gu B; Karimi S; Riedel E; Panageas KS; Edgar MA; Tanwar MK; Rao JS; Fleisher M; DeAngelis LM; Holland EC Clin Cancer Res; 2006 Oct; 12(19):5698-704. PubMed ID: 17020973 [TBL] [Abstract][Full Text] [Related]
9. Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2. Rousseau A; Nutt CL; Betensky RA; Iafrate AJ; Han M; Ligon KL; Rowitch DH; Louis DN J Neuropathol Exp Neurol; 2006 Dec; 65(12):1149-56. PubMed ID: 17146289 [TBL] [Abstract][Full Text] [Related]
10. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma. Perry A; Aldape KD; George DH; Burger PC Cancer; 2004 Nov; 101(10):2318-26. PubMed ID: 15470710 [TBL] [Abstract][Full Text] [Related]
11. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
12. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors. Shukla B; Agarwal S; Suri V; Pathak P; Sharma MC; Gupta D; Sharma BS; Suri A; Halder A; Sarkar C Neurol India; 2009; 57(5):559-66. PubMed ID: 19934553 [TBL] [Abstract][Full Text] [Related]
13. Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells. Junker N; Johansen JS; Hansen LT; Lund EL; Kristjansen PE Cancer Sci; 2005 Mar; 96(3):183-90. PubMed ID: 15771622 [TBL] [Abstract][Full Text] [Related]
14. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas]. Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907 [TBL] [Abstract][Full Text] [Related]
15. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Tanwar MK; Gilbert MR; Holland EC Cancer Res; 2002 Aug; 62(15):4364-8. PubMed ID: 12154041 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas. Antonelli M; Buttarelli FR; Arcella A; Nobusawa S; Donofrio V; Oghaki H; Giangaspero F J Neurooncol; 2010 Sep; 99(2):209-15. PubMed ID: 20174854 [TBL] [Abstract][Full Text] [Related]
17. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma. Saidi A; Javerzat S; Bellahcène A; De Vos J; Bello L; Castronovo V; Deprez M; Loiseau H; Bikfalvi A; Hagedorn M Int J Cancer; 2008 May; 122(10):2187-98. PubMed ID: 18092325 [TBL] [Abstract][Full Text] [Related]
18. [Loss of heterozygosity of chromosome 1p/19q and p53 protein expression in oligodendroglioma]. Xiong J; Liu Y; Li C; Zhu JJ; Ye ZR; Mao Y; Wang Y Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):445-50. PubMed ID: 19781190 [TBL] [Abstract][Full Text] [Related]
19. Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India. Jha P; Agarwal S; Pathak P; Srivastava A; Suri V; Sharma MC; Chosdol K; Srivastava T; Gupta D; Gupta A; Suri A; Sarkar C Cancer Genet Cytogenet; 2010 Apr; 198(2):126-34. PubMed ID: 20362227 [TBL] [Abstract][Full Text] [Related]
20. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]